spacer
home > pmps > winter 2019 > inhalation drug delivery: going generic, getting connected
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Inhalation Drug Delivery: Going Generic, Getting Connected

Over the past five years, generic pharmaceuticals have grown more than twice as fast as patented prescription drugs, a trend that is likely to continue (1). Across the industry, organisations are facing growing pressure to speed up timelines and slim down operating budgets to stay ahead of the competition. Additionally, connected inhalation opportunities are beginning to impact the market, as addressing problems with adherence and usability becomes a priority. Pharma companies entering the market need a partner with a successful track record in inhalation, as well as end-to-end capabilities from formulation and development to contract manufacturing. There may never have been a time when trustworthy partners were more critical to the success of a pharma campaign.

Going Generic

While inhalation generics have been on the market for several years in Europe, there have not been any generic inhalers launched in the US. Filings have been made with the FDA over the years, yet, to date, none have been approved. While the reasons for the delays are not typically made public, the result is obvious: lack of patient access to generic medicines, increased costs, and delayed and/or reduced revenue in the long term to generic pharma providers.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
3M
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement